The use of phytocannabinoids in the treatment of ovarian carcinoma

Research output: Patent

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Use of Phytocannabinoids in the treatment of ovarian carcinoma.
Javid, F., 2018, IPC No. HGF Ltd, Patent No. US14/899613, 19 Jun 2014, Priority date 16 Oct 2016, Priority No. US10098867
Research output: Patent
The use of phytocannabinoids in the treatment of ovarian carcinoma
Javid, F., 2017, IPC No. HGF Ltd, Patent No. GB2014006473, 10 Apr 2014, Priority date 8 Feb 2017, Priority No. GB2516335B
Research output: Patent
The use of phytocannabinoids in the treatment of ovarian carcinoma
Javid, F., 2016, IPC No. HGF Ltd, Patent No. EP2014732614, 19 Jun 2014, Priority date 27 Apr 2016, Priority No. EP3010498A1
Research output: Patent
The use of phytocannabinoids in the treatment of ovarian and skin carcinoma
Javid, F., 2015, IPC No. HGF Ltd, Patent No. GB2014006473, 10 Apr 2014, Priority date 21 Jan 2015, Priority No. GB2516335A
Research output: Patent
The use of phytocannabinoids in the treatment of ovarian carcinoma
Javid, F., 2014, IPC No. HGF Ltd, Patent No. GB2013010910, 19 Jun 2013, Priority date 24 Dec 2014, Priority No. GB2515312A
Research output: Patent